openPR Logo
Press release

Rheumatoid Arthritis Market Size Forecast to Reach $32.4 Billion by 2026

06-18-2021 01:08 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: IndustryARC

Rheumatoid Arthritis Market

Rheumatoid Arthritis Market

Rheumatoid Arthritis Market size is forecast to reach $32.4 billion by 2026, growing at a CAGR of 5.2% during the forecast period 2021-2026. Rheumatoid Arthritis is an auto-immune disorder that affects joints in the knee, and fingers with extra articular organs. Medications such as methotrexate plays as an anti-inflammatory agent in controlling the progression of rheumatoid arthritis and hormones in both genders play a role in either preventing it. Symptoms include pain, tender, stiffness, and swelling of joints. Disease modifying antirheumatic drugs is to mitigate the progression of the disease and recent advancements with biosimilars is used to treat RA and increase in approvals of the same by regulatory affairs. Increasing prevalence of rheumatoid arthritis and increasing launch of novel therapeutic drugs are the major factors driving the growth of the market. Favorable reimbursement policies for high cost treatment products and improvements in diagnosis & healthcare infrastructure is set to further enhance the overall market development of the Rheumatoid Arthritis Market for the period 2021-2026.

Full Report Link @ https://www.industryarc.com/Research/Rheumatoid-Arthritis-Market-Research-507056

Rheumatoid Arthritis Market Segment Analysis – By Product

Synthetic Disease Modifying Antirheumatic Drugs held the largest share in the Rheumatoid Arthritis Market in 2020 and is estimated to grow at a CAGR 4.6% during the forecast period 2021-2026. This is attributed to the rise in awareness related to the use of disease modifying antirheumatic drugs and increasing prevalence of rheumatoid arthritis. Rise in obese and overweight population is also increasing the demand of the drug. Corticosteroids reduce immune system activity as it ease swelling, redness, and allergic reactions. It also used to treat diseases like asthma. Non-steroidal anti-inflammatory drugs cannot treat the disease alone and it needs to be taken along with other rheumatoid arthritis medications. These are beneficial in mitigating symptoms and also prevent the rate of joint damage. Corticosteroids are estimated to register the highest CAGR over the period 2021-2026.

Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=507056
Report Price: $ 5900 (Single User License)

Rheumatoid Arthritis Market Segment Analysis – By Route of Administration

Oral held the largest share in the Rheumatoid Arthritis Market in 2020 and is estimated to grow at a CAGR 5.7% during the forecast period 2021-2026. This is attributed to the higher prevalence of rheumatoid arthritis and it also offers several benefits such as safety, ease of absorption, adaptability to different kinds of drugs, and no pain during administration among others. Oral are estimated to register the highest CAGR over the period 2021-2026.

Rheumatoid Arthritis Market Segment Analysis – By Geography

North America dominated the Rheumatoid Arthritis Market with a major share of 37.3% in 2020. This is attributed to the increasing prevalence of rheumatoid arthritis and increasing awareness about the disorder. Increasing healthcare spending, increasing demand for disease modifying antirheumatic drugs along with the increasing public awareness toward use and benefits of these drugs is increasing the growth of the market in this region.

However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to the increasing penetration of rheumatoid arthritis treatment drugs, specially biologics, and increasing healthcare infrastructure. Increasing awareness and undertaking of treatment of rheumatoid arthritis is also increasing the growth of the market in this region.

Inquiry Before Buying @ https://www.industryarc.com/reports/request-quote?id=507056

Rheumatoid Arthritis Market Drivers

Rising Awareness about Arthritis and its Prevention

Rising awareness about arthritis and its prevention is increasing the growth of the Rheumatoid Arthritis Market. Rheumatoid Arthritis is a disease that cause damage and joint pain throughout the body. It usually happens on the both sides of the body. Though medications have improved treatment options but it can still cause physical disabilities. According to World Health Organization, the prevalence of rheumatoid arthritis varies between 0.3% and 1% and is more common in women and in developed countries and about 1.3 million Americans have rheumatoid arthritis. Thus, increasing the growth of the Rheumatoid Arthritis Market during the forecast period 2021-2026.

Increasing Demand for Disease Modifying Antirheumatic Drugs

Increasing demand for disease modifying antirheumatic drugs is increasing the growth of the Rheumatoid Arthritis Market. Disease modifying antirheumatic drugs treats alters the underlying diseases by reducing pain, stiffness, and swelling over a period of weeks or months. Conventional disease modifying antirheumatic drugs are slow acting and it responds well with the medications. Biological therapies are newer drugs that target individual molecules and it works more quickly than conventional disease modifying antirheumatic drugs. It target a protein called tumor that increases inflammation and are often given in combination with a conventional disease modifying antirheumatic drugs. Thus, increasing the growth of the Rheumatoid Arthritis Market during the forecast period 2021-2026.

Rheumatoid Arthritis Market Challenges

Side Effects Associated with the Consumption of Drugs and High Cost Associated with Biologics & Biosimilars

Some of the factors that are set to impede the growth of the Rheumatoid Arthritis Market are side effects associated with the consumption of drugs and high cost associated with biologics & biosimilars. High cost associated with biological disease modifying antirheumatic drugs therapies and expiry of patents of vital drugs is also set to hinder the growth of the market.

Rheumatoid Arthritis Market Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Rheumatoid Arthritis Market. In 2020, the Rheumatoid Arthritis Market share is consolidated by the top ten players present in the market. Rheumatoid Arthritis Market, top 10 companies are AbbVie Inc., Amgen Inc., Bristol, Eli Lily & Company, Novartis, Pfizer Inc, UCB SA, Squibb Company, and Gilead Science Inc. among others.

Acquisitions/Product Launches

In December 2019, Amgen Inc. received the approval of the US Food and Drug Administration for Avsola, a biosimilar drug rheumatoid arthritis drug.

Key Takeaways

North America dominated the Rheumatoid Arthritis Market in 2020 owing to increasing prevalence of rheumatoid arthritis and increasing awareness about the disorder. The Rheumatoid Arthritis Market scope for different regions will be provided in the final report.

Rising awareness about arthritis along with its prevention among healthcare professional & patients and increasing efficiency of drugs in the treatment of rheumatoid arthritis are likely to aid the market growth of the Rheumatoid Arthritis Market report.

Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Rheumatoid Arthritis Market report.

Side effects associated with the consumption of drugs and high cost associated with biologics & biosimilars is poised to create hurdles for the Rheumatoid Arthritis Market.

Related Reports :

A. Musculoskeletal Diseases Market
https://www.industryarc.com/Report/16117/musculoskeletal-diseases-market.html

B. Immune Checkpoint Inhibitors Market
https://www.industryarc.com/Report/17427/immune-checkpoint-inhibitors-market.html

For more Lifesciences and Healthcare Market reports @ https://www.industryarc.com/Domain/8/lifesciences-healthcare-market-research.html

Venkat Reddy
Sales Director
Email: venkat@industryarc.com
Website: https://www.industryarc.com
Phone: (+1) 970-236-3677

About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rheumatoid Arthritis Market Size Forecast to Reach $32.4 Billion by 2026 here

News-ID: 2308702 • Views:

More Releases from IndustryARC

Professional Diagnostics Market Size to Grow at a CAGR of 6.3% During the Forecast Period 2021–2026
Professional Diagnostics Market Size to Grow at a CAGR of 6.3% During the Foreca …
Professional Diagnostics Market size in 2020 is estimated to be $45 billion, growing at a CAGR of 6.3% during the forecast period 2021-2026. Professional diagnostic is the diagnostic method which are used for faster detection of various diseases such as tuberculosis, cancer, malaria, and others. The main purpose of professional diagnostics is to diagnose or monitor disease in early condition so that treatment can be started so that this diagnostic
Body Dryer Market Size to Grow at a CAGR of 6.0% During the Forecast Period 2021–2026
Body Dryer Market Size to Grow at a CAGR of 6.0% During the Forecast Period 2021 …
Body Dryer Market size was valued at $2,978 million in 2020 and is anticipated to reach $5,143 million by the end of 2026 growing at a CAGR of 6.0% during the forecast period 2021-2026. The Body Dryer industry growth rate is attributed to the rising need to reduce medication errors and development of automated systems with improved features and is likely to new opportunities. Body dryers are type of air
India P2P Lending Market Size Forecast to Reach $10.5 Billion by 2026
India P2P Lending Market Size Forecast to Reach $10.5 Billion by 2026
The India P2P lending Market size is forecast to reach $10.5 billion by 2026, after growing at a CAGR of 21.6% during the forecast period 2021-2026. The Peer to Peer Lending Market growth is attributed to increasing transparency in P2P lending with technologies such as block chain and smart contracts being incorporated into lending platforms. The Indian Government’s enthusiastic promotion of cashless technologies has also managed to restructure the financial
Cloud Relational Database Market Forecast to Reach $18.8 Billion by 2026
Cloud Relational Database Market Forecast to Reach $18.8 Billion by 2026
Cloud Relational Database Market is forecast to reach $18.8 billion by 2026, after growing at a CAGR of 38.4% during 2021-2026. With rise in the adoption of IoT technologies and the usage of cloud database for computing in various organizations for different applications is analyzed to boost the Cloud Relational Database Market. Moreover, the cloud databases provide the customers with improved performance, service resilience and so on, thereby enhancing the

All 5 Releases


More Releases for Arthritis

Canine Arthritis Treatment Market to 2028 |Dechra Pharmaceuticals PLC, Canine Ar …
Market Research Hub (MRH) has carefully analyzed this research study titled Canine Arthritis Treatment Market: Asia Pacific Excluding Japan to Register the Fastest Growth During the Forecast Period: Global Industry Analysis (2013-2017) and Opportunity Assessment (2018-2028), which is available on its online portal. The aim of this assessment is to highlight the various projections expected to occur in the global market for Canine Arthritis Treatment. Readers can gain knowledge related
Arthritis Consumer Experts launches JointHealth™ Education Advanced Therapies …
June 21, 2018 For Immediate Release ACE launches JointHealth™ Education Advanced Therapies North America’s first course designed to educate arthritis patients introduces new lesson on advanced therapies for inflammatory arthritis (VANCOUVER) — Arthritis Consumer Experts (ACE) announced the launch of its newest on-line patient education course: JointHealth™ Education Advanced Therapies for Inflammatory Arthritis. This three-lesson course is designed to help patients living with inflammatory arthritis identify when the appropriate time to transition from conventional
Rheumatoid Arthritis Drug Market Rheumatoid Arthritis Clinical Pipeline Report 2 …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Antirheumatoids: Call of Rheumatoid Arthritis 1.1 Prologue towards Rheumatoid Arthritis 1.2 Obtainable Treatment for Rheumatoid Arthritis Molecular Mechanism of Antirheumatoids 2.1 Purpose of DMARDs in Rheumatoid Arthritis 2.2 Role of Biological Agents in Rheumatoid Arthritis 2.2.1 TNF- Inhibitors 2.2.2 Interleukin -1 and IL-6 Blockers Classification of Rheumatoid Arthritis Drugs 3.1
Rheumatoid Arthritis Treatment Market
Rheumatoid arthritis (RA) is the most common autoimmune arthritis affecting more than 1.3 million U.S. citizens (American College of Rheumatology). More surprising is to know that around 75% of this affected population is women. Affecting the joints at any age, rheumatoid arthritis needs to be addressed early to avoid expensive joint replacement surgery. While it can affect any joint, small joints in hand and feet tend to be affected the
Rheumatoid Arthritis Treatment Market
Rheumatoid arthritis (RA) is the most common autoimmune arthritis affecting more than 1.3 million U.S. citizens (American College of Rheumatology). More surprising is to know that around 75% of this affected population is women. Affecting the joints at any age, rheumatoid arthritis needs to be addressed early to avoid expensive joint replacement surgery. While it can affect any joint, small joints in hand and feet tend to be affected the
Worldwide Arthritis - EpiCast Report: Rheumatoid Arthritis - Epidemiology Foreca …
"EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2025" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- ** Summary Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the bodys immune system attacks the lining of the joints, known as